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Abstract 
 
Purpose: To perform a secondary dose calculation for intensity modulated radiotherapy (IMRT) 
or volumetric modulated arc therapy (VMAT) plans to a point on or off axis within 2% using 
open field data.  
Methods: An independent dose calculation algorithm has been developed for complex fields 
with multiple segments.  The algorithm subdivides dose into the contributions from each 
opposing leaf pair for a given multileaf collimator (MLC) configuration. Leaf pair dose is 
determined by drawing four rectangular fields based on leaf positions, which are symmetric 
about the point of calculation. Superposition of these fields yields the dose from the leaf pair to 
the point. VMAT plans are approximated by a static MLC configuration at four degree intervals. 
The algorithm requires standard open field data (e.g., head and phantom scatter factors, Scps and 
tissue phantom ratios, TPRs), and the MLC control point information. Calculations were done 
with additional measured small field output factors down to a 1.5x1.5-cm
2
 field.
 
Algorithm doses 
to the isocenter or center of the planning target volume (PTV) were compared with 
heterogeneous Pinnacle calculations of a series of prostate, head and neck, and chest wall 
treatment plans. Delivery techniques included fixed gantry IMRT and VMAT. 
Results: Good agreement was obtained between doses calculated by the algorithm and the 
Pinnacle
3
 treatment planning system. Percent errors were -0.2% ± 3.8% (mean and 95% 
confidence interval) for algorithm calculations. Systematic offsets were observed as a function of 
calculation site, with prostate doses being underestimated and chest wall doses being 
overestimated. Errors are likely the result of patient geometry deviations from the infinite slab, 
flat phantom assumption of monitor unit calculations. 
 x 
 
Conclusion: Results demonstrate that clinically acceptable agreement is obtained using this 
method. Further improvement could be made with more accurate heterogeneity correction factors 
and/or a better estimation of small field output factors.  
 1 
 
Chapter 1 :  Introduction 
 
1.1 Background and Significance 
 
1.1.1 IMRT treatments 
 
The goal of external radiation therapy is to deliver a tumorcidal dose of radiation to 
cancerous cells, while minimizing dose to surrounding healthy tissues and critical structures. 
Traditionally, the majority of radiation treatments use beams of uniform intensity across the 
field. Wedges or compensators can modify this intensity profile, while blocks can further shape 
the field. Intensity modulated radiation therapy (IMRT) is a newer technique in which non-
uniform intensity profiles are delivered from multiple angles. The composite of these profiles has 
been optimized to maximize tumor dose, while minimizing dose to surrounding tissues to a 
higher degree than traditional techniques would allow. An example of each treatment is shown in 
Figure 1.1.  
Two systems make this technique clinically possible, a three-dimensional treatment 
planning system (TPS) with the ability to calculate dose from and optimize non-uniform fluence 
patterns, and a method of delivering these planned non-uniform intensity profiles such as a 
multileaf collimator (MLC).
1
 A MLC is a device positioned in the beam line either in addition to 
or replacing one of the photon collimating jaws. It is made up of multiple opposing leaves with 
sufficient thickness to attenuate the photon beam to a level approximately 1-2% of the primary 
beam. These leaves can move perpendicular to the central axis and can be positioned to create 
desired field patterns. An illustration on a MLC is shown in Figure 1.2 as well as a beam’s-eye-
view representation that will be commonly used throughout this work. 
 
 2 
 
 
Figure 1.1: Displayed are axial views of a conventional (a) and IMRT (b) treatment plans each 
with three beams directed towards the prostate at different gantry angles. The red line indicates a 
representative isodose line for each treatment. Although the field sizes and gantry angles for the 
beams are equivalent in each case, the intensity profiles displayed at the source of each beam are 
different, allowing for greater conformity in the IMRT plan. Image adapted from Webb et al.
2 
 
 
Figure 1.2: Example of an MLC. (a) Illustration of a MLC collimating a beam of radiation to a 
desired shape. (b) A beam’s-eye-view representation of the MLC. 
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There are a number of different techniques that have been developed for IMRT. This 
project has focused on the verification of two specific techniques known as segmental multileaf 
collimation (SMLC or SMLC-IMRT), commonly referred to as “step-and-shoot”, and volumetric 
modulated arc therapy (VMAT). SMLC plans generally consist of 9 beams at fixed gantry angles 
spaced around the patient, each with its own optimized fluence distribution. This fluence 
distribution is created by adding together multiple discrete sub-fields called segments. During 
delivery, each segment is exposed for a set number of monitor units (MU) defined by a series of 
control points.  In SMLC deliveries, there is no radiation delivered while the MLC transitions 
between segments.  
 By contrast, VMAT is a continuous delivery with both the gantry and MLC leaves 
moving during the delivery of radiation. VMAT treatments consist of one to two arcs over a 
defined angle around the patient. Radiation is delivered continuously at variable dose rate while 
MLC leaves, photon jaws, and the gantry are in motion. These variables are optimized as a 
function of gantry angle during planning to achieve a desired composite dose distribution. 
VMAT treatments are faster than and exhibit dose distributions equivalent to gantry-static IMRT 
techniques.
3
  
1.1.2 Patient Specific Quality Assurance 
 
Patient specific plan verification has always been a part of quality assurance, with a 
secondary calculation of dose recommended by multiple sources.
4-8
 Conventional treatments 
were verified by hand calculations of the number of monitor units required to deliver a specified 
dose to a single calculation point. This method is impractical for IMRT treatments due to 
irregular field shapes and the large number of segments for each plan. As a result, the current 
practice is to verify IMRT treatment plans using surrogate phantom measurements. The planned 
 4 
 
beams are transferred to a CT of a measurement phantom and dose is calculated. The phantom is 
then irradiated with ion chamber, film, or diode arrays used to measure the dose. Results are 
compared to the calculated dose in the phantom. This is sufficient for the majority of cases, but 
there are some errors that will not be caught by measurements, such as failure to remove the 
couch, incorrect patient data, an incorrect CT-density table, or errors transferring data to the 
record and verify system.
7
 Independent dose calculation methods would catch these errors, 
provided they do not use information from the treatment planning system for input. Ideally, 
output from a record and verify system should be used.
7
 Phantom measurements might 
eventually fall out of use as confidence in secondary dose calculations increase.  
1.1.3 Current IMRT Dose Verification Algorithms 
 
There multiple approaches in the literature for an independent dose calculation of IMRT 
plans. 
9-17
 These range in complexity from Modified Clarkson Integration (MCI) to Monte Carlo 
techniques. There are currently three commercial products based on these algorithms available: 
MuCheck, developed by Oncology Data Systems, Inc. (http://mucheck.com/odsweb/), RadCalc, 
developed by Lifeline Software, Inc. (http://lifelinesoftware.com/index.php), and IMSure, 
developed by Standard Imaging, Inc. (http://www.standardimaging.com/).  
MuCheck and RadCalc are both based on the work of Kung et al.
10
 which is a MCI 
technique. An illustration of the process is shown in Figure 1.3. A delivered fluence grid 
MU(x,y) is built from MLC sequence files from the treatment planning system. Intensity values 
for each beamlet are based on leaf open times plus leakage. Assuming radial symmetry of dose, 
all beamlets r distance from the CAX contribute an equal amount of scatter per monitor unit to 
the point of calculation. This allows the fluence grid to be averaged over concentric annular 
sectors and expressed as the weighted sum of these sectors. Dose from an annular field with 
 5 
 
inner and outer radii of (r, r+Δr) is determined by subtracting a circular field of radius r from a 
field of radius r+Δr. Dosimetric information of circular fields is obtained by assuming a disk of 
radius r to have an equivalent square of 2r x 2r. The algorithm was found to be within 3% of 
values calculated in the Corvus treatment planning system for five SMLC-IMRT plans. This 
method was originally intended for on-axis calculations in a homogeneous medium, but has since 
been extended to off-axis calculations in heterogeneous media for commercial use.  
 
Figure 1.3: Modified Clarkson Integration. The conversion of the MLC sequence to a fluence 
grid to annular dose sectors. Image adapted from Kung et al.
10
 
 
IMSure is based on work done by Yang et al.
13
 which is an extension of the work done by 
Xing et al.
14
 The technique determines point dose by expressing the field as the sum of multiple 
beamlets, weighted according to fractional amount that beamlet is open for the delivery. Beamlet 
specific head scatter factors are determined using a three-source model
13
 and leakage for closed 
beamlets is calculated using an average transmission factor. Dose from each beamlet to the point 
of calculation can be determined by methods ranging from MCI to Monte Carlo simulation. 
Algorithm calculations at isocenter were within 2% when compared to the Corvus treatment 
planning system and in-phantom ion chamber measurements for two plans, with higher errors 
found at off-axis points. Accuracy of this method is highly dependent of the correct 
determination of beamlet dose. 
 6 
 
Monte Carlo methods are the most accurate approaches to dose calculation, however 
execution time is generally prohibitive especially when used as a patient specific check. Fan et 
al.
17
 developed a Monte Carlo approach using the point detector method and next event 
estimation. The probability of a photon reaching the point of measurement from each interaction 
during its random walk is calculated, rather than simply recording energy deposited in the voxel, 
greatly increasing calculation efficiency. Photon energy fluence at point is determined and 
converted to collision kerma by the mass energy absorption coefficient. Results were within 2% 
in low gradient areas for 20 plans when compared to EGS4/MCSIM simulations, with 
calculations being 20 times faster at around 5 minutes. While impressive, Monte Carlo methods 
are impractical for implementation in the average clinic due to the complexity of their 
commissioning process.  
1.1.4 TomoTherapy Dose Calculation Algorithm 
 
Helical TomoTherapy is a specialized delivery system that delivers dose in a helical 
fashion using the same geometry as a CT scanner. For these systems, the fan beam is modulated 
by a one-dimensional, binary MLC. Gibbons et al.
18
 devised a simple, yet accurate method for 
point dose calculations for the helical TomoTherapy system. A modulated field from a single 
projection is shown in Figure 1.4(a), the leaf open time for each leaf is shown with leaf number 
m as the leaf centered over the point of calculation. This projection is approximated by setting 
leaves m ± n equal to their average, resulting in the symmetric projection shown in Figure 1.4(b). 
This symmetric projection may be expressed as the sum of multiple symmetric unmodulated 
segments 1-4 as shown in Figure 1.4(c). Dose of these fields are determined using traditional 
hand monitor unit calculation methods that have been modified for the TomoTherapy treatment 
geometry. Point dose is determined by summing the dose from all projections in the treatment. 
 7 
 
Note that some of these segments may have negative treatment times. While this is not 
physically possible, it is acceptable for dose calculation purposes. The algorithm was used to 
calculate point doses for a number of patient treatment plans, which were compared with the 
point doses determined by the TomoTherapy Treatment Planning System (TPS). Agreement 
between the algorithm and the TPS was within 2% for 94% patient plans (64 of 68) for sites 
other than the lung or superficial planning target volumes (PTV). These sites showed a 
systematic overestimation of dose with an average and standard deviation of 3.1% ± 2.4%. This 
was thought to be due to overestimation of scattering material surrounding the source to point 
ray.  
This algorithm has multiple benefits over previously discussed approaches while still 
being sufficiently accurate for clinical use. It uses open field data which are measured at time of 
machine commissioning and is mathematically simple enough to be verified by hand if needed. 
The dose calculation formalism has been in use for verification of conventional treatments for 
years and is well understood.  
The approach used by Gibbons et al. for helical tomotherapy could be extended to conventional 
MLC IMRT deliveries, provided a methodology was created to convert the two-dimensional 
non-uniform fluence matrix into a summation of uniform, symmetric fluence matrices. In this 
case, the total dose would be computed as a summation of open fields, symmetric about the point 
of calculation. The algorithm would be able to use dosimetric functions already measured for 
conventional MU calculations, and would avoid problems calculating doses from small, 
individual beamlets.  
 
 8 
 
 
Figure 1.4: Example of TomoTherapy algorithm decomposition of a single projection. The 
original leaf open projection (a) is symmetrized about leaf m, yielding a symmetric projection (b) 
that delivers an equivalent amount of dose. This symmetric projection is then expressed as 
superposition of multiple symmetric segments of unmodulated leaf-open fields (c) which can be 
calculated using premeasured data. Image from Gibbons et al.
18
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1.2 Hypothesis  
 
An independent monitor unit calculation algorithm using a superposition of open-field 
data can be used to accurately predict calculated doses for SMLC and VMAT plans to within 2% 
for points in high-dose low gradient regions. 
1.3 Specific Aims 
 
Aim 1: Adapt the TomoTherapy independent dose calculation algorithm for calculation of dose 
from fields delivered with conventional MLCs. 
Aim 2: Obtain dosimetric data as required for input into the algorithm. 
Aim 3: Compare the algorithm to Pinnacle calculations and point dose ion chamber 
measurements of test cases presented in AAPM Report Task Group 119.
19
 
Aim 4: Compare the algorithm to Pinnacle calculations of a series of SMLC and VMAT patient 
plans. 
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Chapter 2 :  Methods and Materials 
 
2.1 Aim 1: Adapt the TomoTherapy Algorithm for Calculation of SMLC and VMAT 
deliveries 
 
2.1.1 The Algorithm’s Approach 
 
As discussed in the introduction, IMRT deliveries use multiple beams with non-uniform 
fluence, the composite of which has been optimized to give a desired dose distribution in the 
patient geometry. In the case of SMLC deliveries, these non-uniform fluence distributions are 
created by adding multiple MLC-defined field configurations, called segments, from the same 
angle to achieve the result. Segments are defined at the linac by control points, which specifies 
the state of the machine (e.g., MLC leaf positions, gantry angle, etc.).  In the case of VMAT 
deliveries, the radiation beam is continuously on while the gantry, jaws, and MLC leaves are all 
in motion. Within the Pinnacle TPS, the VMAT plan is defined by control points placed at 
regular gantry intervals, typically every four degrees, and a cumulative number of monitor units 
that have been delivered when the gantry arrives at each of these computer optimized angles and 
field configurations. In the Pinnacle TPS, the total dose delivered over a four degree arc, 
centered around the control point, is approximated as being delivered at a single gantry angle 
defined at the control point.
8
 So for dose calculation purposes, both SMLC and VMAT deliveries 
are represented as the sum of gantry-static segments, each defined by the planned control points. 
Each control point has its own gantry angle, jaw positions, MLC positions, and number of 
monitor units (MU) associated with it.  
 In this approach, we subdivide control point dose per MU into the contributions from 
each opposing leaf pair gap. Leaf gap dose per MU is determined by the superposition of four 
fields, symmetric about the point of calculation, whose dimensions are based on the corners of 
the gap in question. An example beam’s-eye-view of a MLC defined control point is shown in 
 11 
 
Figure 2.1. In this example, the dose will be calculated to the black dot in the center of the figure.  
Initially, we are calculating the dose to this point due to the radiation delivered between the blue 
leaf pair at the top of the figure. The corners of the leaf gap for this leaf pair are labeled as A, B, 
C, and D.  
 
Figure 2.1: An example control point. The leaf pair to be calculated is shown in blue with the 
corners used labeled A-D. 
 
The points A and B are always the corners of the leaf that is horizontally furthest away 
from the point of calculation, and points A and C are always the corners that are vertically 
farthest from the point of calculation. The dimensions of the four rectangular fields are then 
determined by having a corner at one of the points A through D and their center at the point of 
calculation. The four fields that would be drawn for the sample control point displayed in Figure 
2.1 are shown in Figure 2.2. The fields are labeled A through D based on the points used to draw 
them. 
 12 
 
 
Figure 2.2: Fields A-D. Drawn based on points A-D centered about the point of calculation. 
 
2.1.2 Calculation of Dose per MU of Rectangular Fields 
 
Dose per MU from fields A-D is calculated using the isocentric formalism presented in 
Task Group 71.
20
 A brief summary of the formalism as applied in this project is presented here. 
For an isocentric photon beam calculation, the dose per MU from a field to a point of calculation 
is:  
 
  
   
    (  )    (  )     (       )     (   )  (
   
   
)   (2.1) 
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where: 
D: The absorbed dose at the point of calculation.  
MU: The number of monitor units for the field. 
0D : The dose rate or dose per monitor unit of the user’s beam under normalization conditions. 
d: Depth of the point of calculation. 
deff:   Water-equivalent depth of the point of calculation. 
OAR: Off-axis ratio.  The ratio of the open field dose rate at an off-axis point to that of the same 
field on the central axis at the same depth.   
x: Off-axis distance.  The radial distance from central axis to the point of calculation, 
measured in a plane perpendicular to the central axis at the isocenter.   
rc: The side of the equivalent square for the collimator field size defined at isocenter.   
rd: The side of the equivalent square for the collimator field size projected to depth d.   
Sc: In-air output ratio.  The ratio of the output (i.e., energy fluence) measured in air for a 
given field size to that for the reference field size. Sc represents changes in output due to 
scatter from the flattening filter and photon jaws. 
Sp: Phantom scatter factor.  The ratio of the dose per MU at the normalization depth for a 
given field size in a water phantom to that of the reference field size for the same incident 
energy fluence. Sp represents the changes in dose per MU due to the amount of scatter 
material exposed to primary beam. 
SAD: Source-axis distance.  Distance between the x-ray physical source position and the 
isocenter. 
SPD: Source-point distance.  The distance from the x-ray physical source to the plane 
(perpendicular to the central axis) that contains the point of calculation.  
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SSD:  Source-surface distance.  The distance along the central axis from the physical source to 
the patient/phantom surface. 
TPR: Tissue phantom ratio.  The ratio of the dose rate at a given depth in phantom to the dose 
rate at the normalization depth for a given field size.   
The rectangular fields A-D are converted to their equivalent squares using the   
             ⁄  approximation.1 Output factors Sc and Sp, TPRs and OARs are commonly 
referred to as open field data and are measured at the time of machine commissioning for the 
purpose of hand monitor unit calculations. The data measured for the Elekta Infinity at Mary 
Bird Perkins Cancer Center, Baton Rouge, LA (MBPCC) was used. Normalization conditions at 
MBPCC are a 10x10-cm
2
 field size, 10-cm depth and 90-cm source-to-surface (SSD) distance. 
Additional values for output factors Sc and Sp were measured and calculated as explained in 
Section 2.2. All data used for input to the algorithm is contained in Appendix B. 
2.1.3 Superposition of Fields 
 
Similar to Day’s technique for calculating dose to points behind blocked portions of 
fields,
21
 the dose per MU from fields A-D are superimposed in such a manner that the resultant 
field has the same dimensions as the leaf gap. The superposition depends on the position of the 
point of calculation relative to the leaf gap. We will continue to illustrate the algorithm using the 
example control point and leaf gap shown in Figure 2.1. The first step is to take fields of similar 
width and subtract them from one another. So the dose per MU from field B is subtracted from 
that from field A, and similarly, field D is subtracted from field C. The results are shown in 
Figure 2.3. The resultant fields A-B and C-D each have two sections that are the height of an 
MLC leaf. We then take the dose per MU from field C-D and subtract it from that from field A-
B. The resulting dose per MU is that due to the fields shown on the left side of Figure 2.4. The 
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four subfields in the figure all have the same dimensions, with the top left field being the exact 
size and location of the leaf gap being calculated.  
 
Figure 2.3: First step in the superposition process. On the left is the result of Field A minus Field 
B. On the right is the result of Field C minus Field D.  
 
Mathematically the dose per MU of these four subfields to the point of calculation would 
be:  
     
  (  
    
 )  (  
    
 ) (2.2) 
Where   
 ,   
 ,   
 , and   
  are the doses per MU from rectangular fields A, B, C, and D 
shown in Figure 2.2 to the point of calculation as determined by Equation 2.1. If the point of 
calculation was on the central axis and assuming scatter is radially symmetric, then each of the 
subfields pictured on the left of Figure 2.4 should contribute equally to the point. Therefore, we 
could divide Equation 2.2 by four to determine the dose per MU from the leaf gap to the point of 
calculation.  
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Figure 2.4: Last step in the superposition process. On the left is the result of Field A-B minus 
Field C-D. On the right an illustration of the distances used to determine OARs for superposition 
weighting.  
 
Consider the case presented on the right of Figure 2.4, where the point of calculation is 
off of the central axis, indicated by the black crosshair. The centers of the four subfields are no 
longer the same radial distance from the central axis and the assumption of radial symmetry is no 
longer valid. The OAR factor from TG-71 formalism can be used here to determine the correct 
weighting to give the leaf gap field. The OAR for each subfield is determined based on the 
distance of the geometric center of the subfield distance from the central axis. The distance used 
for the leaf gap field is indicated in Figure 2.4 as OARA. Applying this, the final equation for 
dose per MU from the leaf gap Dg to the point of calculation is:  
  
  
    
                   
[(  
    
 )  (  
    
 )] (2.3) 
  This expression is valid for the case when the point of calculation is horizontally, and 
vertically outside of the leaf pair gap. The order of superposition changes based on the position 
of the point of calculation relative to the leaf gap, other configurations are shown in Appendix A. 
The general equation for dose per MU from any leaf gap to an arbitrary point of calculation is:  
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 )  (  
    
 )]  (2.4) 
where the signs of the   and   operators depend on the position of the point of calculation 
relative to the leaf gap.  
Since an arbitrary leaf gap can be calculated, the dose per MU from the open area of a 
control point called Dopen is simply the sum of all leaf gap doses per MU for each open leaf pair:  
     
  ∑   
 
         
 
  (2.5) 
2.1.4 Leakage and Control Point Dose per MU 
 
Leakage dose per MU through the MLC leaves not covered by the collimator is 
calculated using a single average transmission value α.  In this work  is set to a value of 0.4%. 
This value was measured with a large volume ion chamber with the long axis of the chamber 
perpendicular to the direction of leaf movement. Readings were taken for a 10x10-cm
2
 field 
defined by the collimating jaws and completely blocked with MLCs. This was divided by the 
reading of a 10x10-cm
2
 defined by both the collimating jaws and MLCs. Figure 2.5 shows all 
areas used in the leakage calculation for the sample control point from Figure 2.1.  
First the dose per MU from the area bounded by the collimating jaws is calculated by the 
same approach used to calculate the dose per MU from a leaf gap, this is labeled as DJ. Then the 
dose per MU from the open area of the control point, Dopen, as calculated by Equation 2.5 is 
subtracted, giving the dose per MU from the area covered by the MLC leaves. This is multiplied 
by α to give the leakage dose per MU, DL, through the MLC leaves for the control point. The 
mathematical representation is:  
  
   (  
       
 ) (2.6) 
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This can be combined with Equation 2.5 to give the total dose per MU from a control point to the 
point of calculation, Dctrl:  
     
   (  
       
 )       
  (2.7) 
Which can be simplified to:  
     
  (   )     
     
  (2.8) 
 
 
Figure 2.5: Areas used in leakage calculation. (a) Sample control point with the collimator drawn 
in. (b) The area used to calculate dose per MU   
  is highlighted in blue. (c) The area 
contributing dose per MU      
  is highlighted in red. (d) The area that contributes dose per MU 
  
  is highlighted in green. Leakage dose through the collimating jaws is ignored in this 
calculation. 
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2.1.5 SMLC and VMAT Deliveries 
 
Now that the dose per MU from a control point of an arbitrary MLC configuration can be 
calculated, doses for SMLC and VMAT deliveries are calculated as the sum of their control point 
doses with each control point dose per MU multiplied by their respective number of MU:  
      ∑            
 
              
 
 (2.9) 
 MUc for the algorithm is the same as used by Pinnacle for their dose calculations as 
explained in the 2009 SmartArc white paper from Philips.
8
 
2.1.6 Program Information 
 
The algorithm was coded in MATLAB
®
 R2010a. Required input information is MLC, 
collimator, gantry positions, and number of monitor units for each control point as well as the 
patient coordinates of isocenter and the point of calculation. These values are contained in the 
DICOM plan file exported from Pinnacle. Depths, water-equivalent or effective depths, and the 
SSD to the point of calculation are also required and obtained from a custom script created 
within Pinnacle. Isocenter and point of calculation coordinates are projected to the beam’s-eye-
view of the control point with appropriate corrections made for beam divergence. Intermediate 
steps of the algorithm are recorded for debugging purposes, final output is the individual beam 
and total plan dose. Pinnacle’s values for these doses are extracted from the DICOM plan file for 
direct comparison. 
2.1.7 Rectangular Field Testing 
 
Once the algorithm was programmed, several open rectangular fields were calculated and 
compared to hand calculations to ensure the algorithm was functioning as expected. Fields were 
calculated on and off the central axis for a range of field sizes, depths, SSDs, and monitor units 
 20 
 
values. Fields were always symmetric about the point of calculation, which allowed all 
equivalent squares to be determined mathematically rather than visually. The equivalent square 
table from BJR supplement #25
22
  was used in both the algorithm and hand calculations as the 
decision to utilize the 4∙A/P approximation was made later in the project. This choice of 
equivalent square algorithm should not affect the results as long as the same method was used by 
both the algorithm and the hand calculations. The weighting by OAR as shown in Equation 2.3 is 
also not utilized as it was added later, instead the superposition of the four fields is divided by 
four.  
2.2 Aim 2: Small Field Output Factor Measurements 
 
2.2.1 Output Factors at Small Field Sizes 
 
There are numerous challenges associated with the measurement and calculation of dose 
of small fields. As such, open field data at Mary Bird Perkins Cancer Center is available down to 
a field size of 3x3-cm
2
. This is sufficient for the majority of clinical applications; however the 
algorithm can generate fields with equivalent squares much smaller than this during the 
calculation of leaf gap doses, especially for the leaf pairs adjacent to the point of calculation. 
TPRs and output factors Sc and Sp are the only open field parameters that are a function of field 
size. TPRs do not vary significantly with field size, so linear extrapolation is a reasonable 
approximation of this function below the measured data. Both Sc and Sp are relatively linear at 
larger field sizes, however there is a rapid drop in values at smaller field sizes, especially for Sp. 
Since poor estimation of these values is a source of error in the algorithm, Sc and Sp were 
measured for field sizes smaller than 3x3-cm
2
. 
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2.2.2 Measurement of Sc 
 
The in-air output ratio Sc is measured using an ion chamber in air with enough 
surrounding buildup material for electronic equilibrium and to prevent electron contamination. 
Measurements are taken at various field sizes and normalized against a reference field. Task 
Group 74
23
 has been published specifically to deal with measurement of Sc for megavoltage x-
ray beams. The methods used here for measurement deviate slightly from the Task Group 
recommendations for measurement of Sc at small field sizes for reasons explained in later in this 
section.  
A PTW 30006 farmer ion chamber with a sensitive volume of 0.6 cm
3
 was used in 
conjunction with a cylindrical mini-phantom with a 3 cm diameter and 20 cm length designed to 
fit the chamber. The mini-phantom was aligned with the central axis of the beam at several 
different source-to-point distances (SPD).  This experimental setup put the point of measurement 
of the ion chamber at a depth of 10 cm, the same as the normalization conditions for the open 
field data, while providing enough material for lateral electronic equilibrium. The gantry was 
turned to 270
o
 and the chamber was placed on the treatment couch held by an acrylic stand to 
reduce additional scatter in the measurement. A picture of the setup is shown in Figure 2.6.  
The point of measurement of the ion chamber was aligned to isocenter using the room 
lasers and external markings on the mini-phantom. A small piece of film was placed behind the 
mini-phantom and exposed with the smallest desired field size to ensure the ion chamber was in 
the center of the field and that the long axis of the chamber was aligned with the central axis. 
This was an iterative process, with table shifts and rotations of the setup being made based on 
measurements of the film. A sample film is shown in Figure 2.7.  
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Figure 2.6: The ion chamber and mini-phantom setup used to measure Sc. The center of the 
sensitive volume of the ion chamber is at the geometric center of the mini-phantom, indicated by 
the black cross. 
 
 
Figure 2.7: Film of a well aligned mini-phantom. There is sufficient and equal flash around all 
sides of the phantom. Concentricity of circles indicate alignment of the chamber axis with the 
central axis of the machine. 
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The mini-phantom was exposed for a set number of monitor units three times per 
measurement session, for various fields decreasing from the normalization field size. The entire  
mini-phantom must be contained within the primary beam for each measurement so that in-
phantom scatter remains constant. This means, for example, that if the chamber is at isocenter, a 
3x3 cm
2
 square field is too small to be measured, since the front edge of the phantomwould be 
clipped as the field size at 90 cm from the source is 2.7x2.7-cm
2
. Since fields smaller than 3x3-
cm
2
 are desired, the chamber is placed at extended distance. Field divergence allows for the 
measurement of smaller fields, while providing sufficient flash around the phantom. However 
this gives rise to certain effects that must be taken into account. 
At small field sizes, changes in output in-air are primarily due to the direct source-
obscuring effect. While the primary x-ray source is always visible, the scattered photon source 
(sometimes called the extrafocal source), which primarily originates from the flattening filter, 
can become obscured by the collimator jaws, which results in a substantial reduction in output.
23
 
From the view of the point of measurement of the ion chamber looking back at the treatment 
head (point’s-eye-view or PEV), the visible amount of extrafocal source changes as a function of 
SPD. As the point of measurement moves farther from the treatment head, the amount of 
flattening filter visible deceases for the same nominal collimator setting, as shown in Figure 2.8. 
Therefore, if measurements were taken at extended SPD and normalized to a nominal 10x10-cm
2
 
field, the resultant Sc values would be different. 
 To account for this, a correction based on work done by Lam and Haken
24
 is used. For 
each measurement at extended SPD, the size of the field from the PEV as defined by the upper 
edges of the collimators projected to the plane of the flattening filter is: 
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Figure 2.8: An illustration of the change in visible flattening filter from the PEV, as limited by 
the top of divergent collimator jaws, as a function of SPD in the measurement of Sc. 
Measurements at isocenter (red) have a larger view of the extrafocal source of scatter than those 
at extended distances (blue).  
 
       
   
   
 
       
       
   (2.10) 
where: 
rff:  The size collimator opening for the photon jaw being projected in the PEV to the plane of 
the flattening filter. 
rn: The nominal collimator setting for the jaw being projected. Defined in the plane of 
isocenter. 
SCD: Source-collimator distance. The distance from the physical x-ray source to the top of the 
jaw being projected. 
SFD:  Source-flattening filter distance. The distance from the physical x-ray source to the 
bottom of the flattening filter. 
Other terms in the equation were defined in Section 2.1.2. The calculation of rff is 
performed individually for the X and Y sizes, since they correspond to the upper and lower 
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photon jaws, each of which has a different SCD. Once the collimator size has been projected to 
the plane of the flattening filter in the PEV, Equation 2.10 can be modified to solve for the 
nominal jaw setting that gives the same PEV field size at the flattening filter:  
         
   
   
 
       
       
 (2.11) 
Where riso is the field size at isocenter that has the same PEV field size as the point at 
extended SPD. Sc values are graphed as a function of riso instead of rn, correcting for changes in 
the amount of effective x-ray source visible as a function of SPD.  
Output factors were measured at SPDs of 1-m, 2-m and 3.07-m. Nominal field sizes rn 
were chosen to give a desired riso. The largest riso for each SPD was set to a 10x10-cm
2
 field. This 
allowed for easy aggregation of the data from different SPDs. Multiple ion chamber readings 
were taken for each field size and averaged. Sc values were normalized to a riso of 10x10-cm
2
. 
SCDs of the top and bottom collimators were 29.5-cm and 43.1-cm respectively and the SFD 
was 15.9-cm. Values were obtained from of the MLCi2 geometry in the Elekta User Manual. 
Data was taken in two different sessions and averaged together for the final values. 
2.2.3 Determination of Sp 
 
The phantom scatter factor Sp was determined indirectly from the in-water output ratio 
Scp, and Sc. Scp is measured using an ion chamber placed in scattering material while changing 
the field size. Measurements are normalized against a reference field size. An Exradin A16 
chamber was used with a sensitive volume of 0.007-cm
3
. It was placed in solid water with a 
chamber specific cavity at 90-cm SSD, 10-cm depth, with 11-cm of back scatter material. The 
gantry was set to 0
o
  and the chamber was roughly aligned to the central axis using the light field 
crosshair and external markings on the solid water slab.  
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To ensure that the chamber was centered within the small fields, the chamber position 
was adjusted until the signal was maximized.  The collimators were set to the smallest field size 
and measurements were taken while first shifting the couch laterally in 0.1-cm increments 
looking for the point of maximum signal. The superior/inferior direction was then searched in a 
similar manner placing the chamber in the center of the smallest field size.  
Once the chamber was centered, measurements were taken at various field sizes ranging 
from 1x1 to 10x10-cm
2
. Megavoltage portal images of the setup using the EPID were taken at 
each field size, imported into RIT113 v6.0 where the full width at half maximum (FWHM) of the 
radiation across perpendicular directions of the field was determined. Data for a nominal 
collimator setting of 1-cm
 
was dropped as the EPID data was saturated in the center of the field, 
giving an inaccurate FWHM. FWHM field sizes and ion chamber readings from two 
measurement sessions were averaged together. A three point quadratic interpolation was then 
used to change Scp from FWHM field sizes to desired field sizes that aligned with riso values for 
the Sc measurements. 
After Sc, and Scp were successfully measured, data existed for both at field sizes of 1.5, 
1.67, 2, 2.5, 3, 4, 5, 7.5, and 10x10-cm
2
. Scp values were then divided by Sc to determine Sp. 
Percent errors against data book values were calculated for Sc and Sp using the equation: 
        (
        
     
  )       (2.12) 
2.2.4 Exponential Fits of Output Factors 
 
A field size of 1.5x1.5-cm
2
 is the smallest size we could measure with reasonable 
certainty. However the algorithm may require calculation of rectangular fields whose equivalent 
squares are smaller than this, so accurate extrapolation of output factors was required. In this 
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project we assumed the output reaches a value of zero at zero field size and output factors below 
measured data follow an exponential function in the form of:  
  ( )   (       ) (2.13) 
Where a and b are fitting parameters, and r is the field size. Since output factors are 
relatively flat with a fall off at smaller field sizes, a limited number of points were used when 
fitting instead of the entire curve. The three smallest field sizes were used for each curve and the 
fit was verified to give good agreement at the smallest measured field size. Fit values for output 
factors were only used for field sizes below measured data. 
2.3 Aim 3: Compare the Algorithm Against Pinnacle and Ion Chamber Measurements of 
AAPM Report Task Group 119 Cases 
 
2.3.1 Summary of AAPM Report Task Group 119 
 
The report from AAPM Task Group 119: IMRT commissioning
19
 outlines an approach as 
well as standards for commissioning a clinic’s IMRT planning and delivery systems. They 
presented multiple sets of contours that are placed on a dosimetry phantom within the treatment 
planning system. The geometries are representative of sites commonly treated with IMRT. Dose 
goals for each site as well as beam arrangements were specified. Plans are delivered on a 
dosimetry phantom and measured at various recommended points with an ion chamber. The 
report specifies a confidence limit or interval of acceptable differences between planned and 
measured values.  
Mancuso et al. planned, delivered, and measured the TG-119 cases using both VMAT 
and SMLC-IMRT deliveries at our institution.
25, 26
 Using the algorithm to independently 
calculate doses from these plans would indicate the algorithm performance for representative 
IMRT geometries and allow for comparison against dose measurements as well as values 
calculated by Pinnacle.   
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2.3.2 Commissioning Process Performed by Mancuso et al. 
 
Four of the TG-119 geometries were investigated, the multitarget, mock prostate, mock 
neck, and C-shape. Cross-sectional slices of the structure set of each case as are available for 
download at http://www.aapm.org/pubs/tg119/default.asp and shown in Figure 2.9. For each 
geometry, TG-119 supplies DVH dose goals for each structure, (Table 2.1) the beam 
configuration for an SMLC delivery to be used, as well as points of comparison for 
measurement.  
 
Figure 2.9: Cross sectional slices of the TG-119 test geometries. (a) Multitarget, (b) mock 
prostate, (c) mock neck, and (d) C-shape geometries. From Mancuso et al.
26
 
 
TG-119 structure sets were copied onto a cylindrical cheese phantom and planned 
according to the report’s protocols. In addition to the SMLC plans outlined in the report, VMAT 
plans for each site of one to two arcs that met the same dose goals were created. Plans were 
delivered to the phantom and ion chamber measurements were taken at points specified by the 
 29 
 
report. Ion chamber measurements were taken five times for each point and a mean dose was 
determined. Ion chamber calibration followed the recommendations of TG-119. A 10x10-cm
2
 
parallel opposed AP-PA plan was created in Pinnacle. The ion chamber was placed closest to the 
center of the phantom and prescribed 200 cGy. The plan was delivered and a ratio of cGy to 
electrometer reading was determined. Dose was also determined using the calibrated ND,w of the 
chamber, the Pelec of the electrometer, and using temperature and pressure corrections to the ion 
chamber readings. Calibration methods calculated dose values within 0.6% for all measurement 
sessions.
26
 Measurements were also taken in the coronal and sagittal planes with a commercial 
2D diode array and radiochromic film. In this work, comparisons were only made against the 
point ion chamber measurements. 
Table 2.1: Dose goals for the TG-119 geometries. Adapted from TG-119.
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Planning parameter Plan goal (cGy)  Planning parameter Plan goal (cGy) 
Multitarget 
  
Prostate 
 
Central target D99 > 5000  Prostate D95 > 7560 
Central target D10 < 5300  Prostate D5 < 8300 
Superior target D99 > 2500  Rectum D30 < 7000 
Superior target D10 < 3500  Rectum D10 < 7500 
Inferior target D99 > 1250  Bladder D30 < 7000 
Inferior target D10 < 2500  Bladder D10 < 7500 
Neck  
 
C-shape  
PTV D90 5000  PTV D95 5000 
PTV D99 > 4650  PTV D10 < 5500 
PTV D20 < 5500  Core D10 < 2500 
Cord maximum < 4000    
Parotid D50 < 2000    
 
For this work, Pinnacle
3
 back-ups of the plans were restored and the data necessary to run 
the algorithm were extracted. Each point with an ion chamber measurement was calculated for 
comparison by MuCheck version 8.2 and the algorithm as explained in Sections 2.4.5 and 2.4.6 
respectively. 
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2.3.3 Test Case Geometry Description 
 
The multitarget geometry consists of three cylindrical targets stacked along the axis of 
rotation, with the center of the middle target at isocenter. Each target has a different dose goal, 
the middle being the highest at 50 Gy. The superior target receives 50% and the inferior 25% of 
the middle target’s goal. Seven fields at 50o gantry intervals from the vertical with 6 MV energy 
were used in planning. Ion chamber measurements were made at center of each target. 
The mock prostate contains a central planning target volume (PTV) that overlaps with the 
rectum and bladder. Seven fields at 50
o
 gantry intervals from the vertical with 6 MV energy were 
used. Ion chamber measurements were made in the center of the PTV at the isocenter, as well as 
in the center of the rectum and bladder. 
The mock neck has a central PTV with critical structures being lateral parotids and a 
posterior spinal cord. Nine fields at 40
o
 gantry intervals from the vertical with 6 MV energy were 
used. Ion chamber measurements were made in the center of the PTV at isocenter and at the 
center of the spinal cord. 
The C-shape geometry consists of a curved target surrounding a cylindrical critical 
structure centered at isocenter. Nine fields at 40
o
 gantry intervals from the vertical with 6 MV 
energy were used. Ion chamber measurements were made at isocenter and in the center of the 
PTV, which was located directly anterior to isocenter. There were two sets of prescribed dose 
goals for the C-shape, the easier one being used in this work.  
2.4 Aim 4: Compare the Algorithm Against Pinnacle for Patient Plans 
 
2.4.1 Overview 
 
In order to evaluate clinical performance of the algorithm, a series of clinical plans of 
patient geometries were calculated. Three sites were chosen for investigation, the prostate, neck, 
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and chest wall. For each site, five patients with VMAT plans were found and placed in a 
HIPAA-compliant database. For each of the patient datasets, SMLC plans were created using the 
same dose goals as the VMAT plans. This gives five plans per modality per site, for a total of 
thirty patient plans.  Dose was evaluated at one point for each plan selected as explained in 
Section 2.4.4. Pinnacle dose was compared against results from calculations using MuCheck 
v8.2 and the algorithm as explained in Sections 2.4.5 and 2.4.6 respectively. 
2.4.2 Selection of Sites 
 
These sites were chosen as they are common places for IMRT delivery and each has 
unique calculation challenges. The prostate has few heterogeneities, relatively simple geometry, 
and the point of calculation is at isocenter. The head and neck has multiple small heterogeneities 
such as airways, the spinal cord, and jaw bones. It is geometrically complex with critical 
structures adjacent to or in target volumes, with a point of calculation near the isocenter. The 
chest wall has large tissue air interfaces due to the proximity to the lung and is a curving target 
that covers a large volume. The point of calculation is far from isocenter, which is usually placed 
in the lung.  
2.4.3 Plan Selection and Creation 
 
Five patients were found for each site that had VMAT plans consisting of one or two 
arcs. Each plan had been previously approved for treatment by a physician. SMLC plans were 
created with the goal of matching the DVH and coverage of the original VMAT plans. For the 
prostate and neck sites, nine beams at 40
o
 intervals from the vertical were used. For the chest 
wall, beams were placed at 30
o
 intervals across the span of the VMAT arc, resulting in seven to 
eight beams per plan. All plans were calculated using Pinnacle version 9.2. The standard Mary 
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Bird Perkins Cancer Center optimization protocol for SMLC planning was used.  The 
optimization parameters are listed in Table 2.2.  
Table 2.2: DMPO optimization parameters used for SMLC plans. 
 
DMPO Optimization Parameters Value 
Max Iterations 40 
Convolution dose iteration 16 
Stopping tolerance 1e-05 
Apply tumor overlap function No 
Allow jaw motion Yes 
Use current jaws as max No 
Split if necessary No 
Maximum number of segments 10 times the number of beams 
Minimum segment area 4 
Minimum segment MUs 4 
Minimum number of leaf pairs 4 
Minimum leaf end separation 4 
Minimum overlap distance 2 
Maximum overlap distance 4 
Compute final dose Yes 
Use SVD for dose calculation No 
 
The optimization was terminated when the DVHs of the SMLC plans were found to be 
equal to the results from the corresponding VMAT plan. At least one SMLC plan of each site 
was reviewed by a dosimetrist and determined to be sufficiently matched and clinically 
acceptable. 
2.4.4 Selection of Calculation Point 
 
The appropriate selection of a point of calculation for a second check is vital in achieving 
an accurate verification. Areas of electronic disequilibrium should be avoided, such as found in 
high-gradient regions, near tissue interfaces, and within 2 cm of field edges.
5
 Unfortunately, 
since IMRT treatments are made of the sum of multiple smaller fields, it is impossible to avoid 
field edges of all subfields when choosing a calculation point.  
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Calculation points for the VMAT plans were chosen during the initial planning by a 
dosimetrist. The point was manually placed on the slice with the largest area of the PTV in the 
center of the PTV contour on that slice. This was generally a high dose, low gradient region in 
homogeneous tissue. For this project those were the points used for the calculation of plans 
unless they were within 1 cm of a tissue interface. In this case it was moved on the same slice 
until it was 1 cm away from the interface. One point was used for comparison for each patient 
for the SMLC and VMAT plans. 
2.4.5 MuCheck Calculations 
 
Secondary calculations of IMRT plans at Mary Bird Perkins Cancer Center are currently 
performed using MuCheck version 8.2. All points calculated by the algorithm are also calculated 
using this software as it is useful to be able to compare against the current standard of care. Off-
axis VMAT points are excluded from all statistical analysis as they are not intended for 
calculation by the version of MuCheck used in this work for two reasons.  
The first being that only average values for SSDs, depths, and effective depths are used in 
the calculation. This is a reasonable approximation if there is not a large variation in depth over 
the range of the VMAT arc, such as for prostate plans, where the point of calculation is in the 
center of a homogeneous area of the patient. For chest wall treatments, this is less valid as the 
isocenter is usually placed in the lung with the point of calculation in the chest wall itself.  
The second reason MuCheck fails for these calculations is that the current version does 
not account for changes in off-axis position as a function of gantry angle. Thus, for each VMAT 
control point, MuCheck places the calculation point at the same location within the beams eye 
view projection for all gantry angles. This is incorrect for all points outside of the isocenter.  
Since MLC patterns for VMAT deliveries are generally a thin opening that sweeps from one side 
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of the field to another, this means that the point of calculation can be erroneously placed outside 
the field for a majority of the control points being calculated.  
MuCheck requires pinnacle-exported DICOM files with SSDs, geometric depths, and 
effective depths to the point of calculation being manually input. Isocenter and point of 
calculation DICOM coordinates are also required for projection of the point of calculation into 
the beam’s-eye-view.  
2.4.6 Algorithm Calculations 
 
The point of calculation is created as a point of interest within Pinnacle and selected as 
the reference point for monitor unit calculations. This ensures that the correct point coordinates 
are contained in the exported DICOM file. The RT plan is exported using the DICOM export 
functionality contained within Pinnacle. A custom script is then executed that writes SSDs, 
depths, and effective depths to the point of calculation to a text file. This text file, along with the 
RTPLAN DICOM file, contain all necessary plan information for algorithm calculations.  
Open field data is contained in comma separated value spreadsheets that are read by the 
algorithm at time of execution. All algorithm calculations in this project were done with 
additional measured small field output factors, as explained in Section 2.2, and with exponential 
fits of output factors for small field sizes as explained in Section 2.2.4.  
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Chapter 3 :  Results and Discussion 
 
3.1 Rectangular Field Calculations 
 
The results of the rectangular fields along with their parameters needed for hand 
calculations are listed in Table 3.1 and Table 3.2 for the on- and off-axis calculations, 
respectively.  
Table 3.1: Parameters and results of rectangular fields calculated on the central axis. 
 
Central Axis Calculations 
Field Number 1 2 3 4 5 6 7 
X Field Size (cm) 10 10 19 7 5.75 3.25 10.75 
Y Field Size (cm) 10 10 7 19 10.25 35.75 20.25 
Depth (cm) 10 10 10 10 2 12.2 23.75 
SSD (cm) 90 90 90 90 80 99.8 109.3 
Monitor Units 100 150 100 100 100 100 100 
Algorithm Dose (cGy) 80 120 80 80 145.8 54.3 30.4 
Hand Calculation Dose (cGy) 80 120 80 80 145.8 54.3 30.4 
 
Table 3.2: Parameters and results of rectangular fields calculated off the central axis. 
 
Off Axis Calculations 
Field Number 8 9 10 11 12 13 14 15 
Point of 
Calculation (x,y) 
2, 2 5, -5 -12, 8 9, -15 5.3, -6 5.3, -6 -6, 5.3 -6, 5.3 
X Field Size (cm) 10 10 13 14 10.2 14.75 10.2 14.75 
Y Field Size (cm) 10 10 18 8 14.75 10.2 14.75 10.2 
Depth (cm) 10 10 10 2.5 7.2 7.2 7.2 7.2 
SSD (cm) 90 90 90 85 97.7 97.7 97.7 97.7 
Monitor Units 100 100 100 100 100 100 100 100 
Algorithm Dose 
(cGy) 
81.0 81.3 85.2 134.4 83.8 83.8 83.8 83.8 
Hand Calculation 
Dose (cGy) 
81.0 81.3 85.2 134.4 83.8 83.8 83.8 83.8 
 
All fields show exact agreement between the algorithm and hand calculations. This is 
expected as both methods use the same input data and make the same assumptions. This 
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demonstrates that field data are being correctly read and interpolated by the algorithm and 
equivalent squares are being correctly determined.  
3.2 Output Factors 
 
Data table and measured output factors are shown in Table 3.3. As explained in Section 
2.2.3, Sp was not directly measured; rather it was found by dividing Scp by Sc. Percent errors 
between measured and data table values are well within 1% for all cases. Values for the fitting 
parameters in Equation 2.13 for all fits are displayed in Table 3.4. 
Table 3.3: Results of output factor measurements. Compared against data table values. 
 
Field Size  
(Side of the Equivalent Square) [cm] 
Measured Values Data Table Values 
Sc Sp Scp Sc Sp Scp 
10 1 1 1 1 1 1 
7.5 0.988 0.966 0.955     
5 0.975 0.922 0.900 0.973 0.927 0.903 
4 0.968 0.906 0.876     
3 0.957 0.880 0.842 0.954 0.884 0.843 
2.5 0.955 0.863 0.823     
2 0.950 0.834 0.793     
1.67 0.947 0.806 0.763     
1.5 0.941 0.768 0.722       
 
Table 3.4: Exponential fitting parameters for output factors. Variables are listed for Equation 
2.13. 
Fitting Parameter 
Measured 
Sc Sp 
a 0.953 0.909 
b 2.938 1.263 
 
Figure 3.1 and Figure 3.2 are graphs of the measured values and their fits for Sc and Sp 
respectively. The data used in the exponential fit are denoted by a solid line through the 
measured points while extrapolated data are shown by a dashed line. Fit values were only used 
by the algorithm below a field size of 1.5x1.5-cm
2
. Both fits display a smooth transition from 
data to the fit.  
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Figure 3.1: Graph of Sc versus field size. 
 
Figure 3.2: Graph of Sp versus field size. 
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3.3 TG-119 Test Cases 
 
For each test case, each point with an ion chamber measurement (listed in Section 2.3.3) 
was calculated by Pinnacle version 9.0, MuCheck version 8.2, and the algorithm.  Percent errors 
against the ion chamber measurements and Pinnacle-calculated point doses were determined for 
both the MuCheck and algorithm calculations using Equation 2.12. None of the ion chamber 
measurements were made at isocenter, so for reasons explained in Section 2.4.5, no VMAT plans 
were calculated by MuCheck for this aim. Additionally, MuCheck was not able to calculate two 
points, the PTV in the C-shape geometry and the bladder in the mock prostate. The error given 
was that a point was outside of the field for a beam in the plan. 
Mean values for algorithm calculations are higher than desired. The percentage of plans 
that have errors of 2% or less were 55% (11 of 20) and 65% (13 of 20) when compared against 
Pinnacle and ion chamber measurements respectively. This is significantly lowered than desired. 
Since all available points were used when determining these results, some points do not meet the 
criteria listed in Section 2.4.4 for acceptable points for a secondary calculations. Excluding 
points that do not meet the criteria leaves only the PTV for calculation for each geometry. 
Table 3.5 shows mean percent errors with standard deviations for all plans grouped by 
calculation method and modality as compared against Pinnacle doses and ion chamber 
measurements. Full results are contained in Appendix C. As compared to MuCheck, the 
algorithm had equivalent mean errors but with noticably smaller standard deviations. These 
indicate that the algorithm had more precise calculations than MuCheck.  
Mean values for algorithm calculations are higher than desired. The percentage of plans 
that have errors of 2% or less were 55% (11 of 20) and 65% (13 of 20) when compared against 
Pinnacle and ion chamber measurements respectively. This is significantly lowered than desired. 
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Since all available points were used when determining these results, some points do not meet the 
criteria listed in Section 2.4.4 for acceptable points for a secondary calculations. Excluding 
points that do not meet the criteria leaves only the PTV for calculation for each geometry. 
Table 3.5: Results of all TG-119 calculation points. Mean percent errors and standard deviations 
aggregated by calculation method. 
 
Calculation 
Method 
Pinnacle % Error Measurement % Error 
All Plans 
Mean ± Std. Dev. 
[%] 
Mean ± Std. Dev.  
[%] 
MuCheck   -3.2 ± 12.5   -1.4 ± 10.3 
Algorithm -3.9 ± 3.7 -1.7 ± 2.8 
SMLC   
MuCheck  -3.2 ± 12.5   -1.4 ± 10.3 
Algorithm -3.3 ± 2.8 -1.7 ± 3.0 
VMAT   
MuCheck N/A N/A 
Algorithm -4.5 ± 4.5 -1.7 ± 2.8 
 
Table 3.6 shows mean percent errors with standard deviations for all plans for only 
acceptable calculation points. When compared against Pinnacle doses, there is little difference 
observed between MuCheck and algorithm calculations. When compared against ion chamber 
measurements mean values are equivalent for both methods, while MuCheck has significantly 
lower standard deviations. The percentage of plans that have errors of 2% or less were 88% (7 of 
8) and 88% (7 of 8) when compared against Pinnacle and ion chamber measurements 
respectively. All metrics show improvement once unacceptable points of calculation are 
excluded, indicating that performance of both algorithms improve when the point is in a high 
dose, low gradient region. Excluding unacceptable points greatly reduces statistics of the points 
weakening any further conclusions. 
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Table 3.6: Results of acceptable TG-119 calculation points. An acceptable point meets the 
criteria outlined in Section 2.4.4. 
 
Calculation 
Method 
Pinnacle % Error Measurement % Error 
All Plans 
Mean ± Std. Dev. 
[%] 
Mean ± Std. Dev.  
[%] 
MuCheck -2.1 ± 1.3 -0.8 ± 0.1 
Algorithm -1.5 ± 1.1 -0.4 ± 1.4 
SMLC     
MuCheck -2.1 ± 1.3 -0.8 ± 0.1 
Algorithm -1.5 ± 0.4 -1.0 ± 1.8 
VMAT     
MuCheck N/A N/A 
Algorithm -1.6 ± 1.5 0.2 ± 0.9 
 
3.4 Patient Plans 
 
The algorithm was used to calculate a point dose for SMLC and VMAT plans of 15 
patients evenly divided between the prostate, neck, and chest wall as explained in Section 2.4. 
Percent error values for each plan were calculated using Equation 2.12 with the Pinnacle dose as 
the known value. A table with the results of all plans is included in Appendix D.  
Table 3.7 shows mean percent errors and 95% confidence intervals for each calculation 
method as a function of modality. Algorithm calculations show lower average errors and 95% 
confidence intervals than MuCheck calculations with the most significant improvement being to 
the confidence intervals. While there is some slight difference in SMLC and VMAT plans for 
algorithm calculations, it is not appreciable. Little to no difference is expected as the calculation 
method is the same and monitor units are assigned to control points in the same manner as 
Pinnacle. 
Figure 3.3 and Figure 3.4 are histograms of percent errors for MuCheck and algorithm 
calculations respectively with different anatomical sites noted. MuCheck exhibits a wide range 
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of errors with no apparent correlation as a function of site. Algorithm calculations are spread 
over a much smaller interval. Systematic offsets are apparent for each site, prostate doses being 
underestimated and chest wall doses being overestimated. Neck calculations are well centered 
near zero. 
Table 3.7: Results of patient plan calculations aggregated by modality. 
 
All Sites 
MuCheck % Error Algorithm % Error 
Mean ± 95% Conf. 
Int. [%] 
Mean ± 95% Conf. 
Int. [%] 
Both 0.7 ± 7.2 -0.2 ± 3.8 
SMLC 0.8 ± 7.3  0.2 ± 4.1 
VMAT 0.3 ± 7.5 -0.6 ± 3.4 
 
 
 
Figure 3.3: Histogram of percent errors for MuCheck calculations. 
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Figure 3.4: Histogram of percent errors for algorithm calculations. 
Table 3.8 shows the mean percent errors and the 95% confidence interval grouped by site 
for each calculation method. The mean error for algorithm calculations of the prostate is greater 
than MuCheck, lower for neck calculations, and roughly equivalent for chest wall calculations. 
Systematic offsets are apparent with roughly a 2% underestimate and overestimate of dose for 
the prostate and chest wall, respectively. Reasons for this are presented later in this section. 
Confidence intervals show improvement in all cases indicating a more precise calculation than 
MuCheck.  
The TG-71 dose calculation formalism is a dose calculation model that is based on a few 
assumptions, deviation from which is the source of these observed errors. One assumption is that 
the field being calculated is square, as data tables are built using measurements of square fields. 
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Table 3.8: Results of patient plan calculations aggregated by treatment site. 
 
Site 
MuCheck % Error Algorithm % Error 
Mean ± 95% Conf. 
Int. [%] 
Mean ± 95% Conf. 
Int. [%] 
All Sites  0.7 ± 7.2 -0.2 ± 3.8 
Prostate -1.0 ± 5.8 -2.1 ± 0.9 
Neck  3.3 ± 8.8 -0.3 ± 2.4 
Chest Wall  1.6 ± 5.1  1.8 ± 2.5 
 
algorithm itself is a way of converting an arbitrary field shape defined by an MLC to a 
superposition of square fields. It is likely that the algorithm has systematic errors when 
calculating fields with certain shape characteristics. It is also possible that plan optimization 
commonly results in site specific field shapes, such as a long thin MLC opening that sweeps 
across the field for chest wall treatments. It is therefore possible that the observed systematic 
offsets appear as a function of anatomical site due to errors in calculating the fields commonly 
used to treat them. A method for investigating this is presented in Section 4.3. 
Conversely, MLC configurations for a given patient geometry can vary for each 
optimization. This, along with the large number of control points for each IMRT plan, makes it 
difficult to associate certain control point MLC configurations with an anatomical site. Since the 
conversion process is the same regardless of site, it is safe to assume any errors in this process 
would appear in all calculations as a baseline systematic offset.  
Another assumption is the beam is perpendicularly incident on a flat phantom geometry. 
The majority of patient external contours are convex, so more scattering material than is present 
is assumed, increasing the algorithm dose.   This approximation is probably reasonable for sites 
with slowly-varying external contours such as in prostate treatment plans.  However, superficial 
sites, such as for the chest wall, may exhibit more changes in scatter which result in worse 
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agreement.  This was previously demonstrated in the results for TomoTherapy second check 
calculations.
18
 
Heterogeneities are accounted for by assuming infinite slab geometry. The composition is 
determined by the material along the source to point ray and is incorporated in the calculations as 
an effective depth. Change in patient heterogeneities lateral to this ray could cause an 
overestimation or underestimation of dose depending on the relative density due to changes in 
scatter contribution.  
All data tables are also measured at isocenter, with off-axis points being calculated with 
central axis data and an OAR which is a function of off-axis distance and depth. At our center 
the OAR which is measured with a 40 cm
2
 field as a function of depth. This ratio has some field 
size dependency due to scatter contributions which is not accounted for and can lead to errors of 
greater than 5% for points more than 10 cm from the central axis.
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For the prostate the radius of curvature of the outer edges of the patient is large with little 
variation in the superior/inferior direction. It is also relatively homogeneous compared to other 
sites, the femoral heads being the main bony structures. For this work, isocenter was the point of 
calculation for all prostate plans. Out of the three sites, the prostate most closely agrees with the 
assumptions of the dose calculation formalism. The systematic underestimation of dose for this 
site is representative of the baseline error of the algorithm.  
The neck has a much smaller radius of curvature, leading to overestimation of dose and is 
likely the main contributing factor to doses being higher than the prostate. The presence of the 
jaw can lead to an underestimation or overestimation of dose depending on the position of the 
point of calculation however it is not a factor in all cases. Similarly, heterogeneities can be bone 
or airways and their influence depends on the point of calculation and beam positions making 
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generalizations difficult. Points of calculation are generally near isocenter where the off-axis 
calculations are appropriately accurate. 
The chest wall plans have points of calculation that are far off-axis with the off-axis 
distance in the beam’s-eye-view varying as a function of beam angle. Beams with small off-axis 
distances will be perpendicularly incident on the patient with surface contours similar to that of 
the prostate. The lung will be downstream from the point for these beams so changes in scattered 
dose will be minimal. Beams with the largest off-axis ratios deviate significantly from the 
assumptions above. These beams will be obliquely incident on the chest wall and in extreme 
cases will be close to parallel with the surface. The chest wall has air on one side and lung on the 
other and can be extremely thin in certain patients, violating the infinite slab geometry, leading 
to an overestimation of dose.  
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Chapter 4 : Conclusions 
 
4.1 Hypothesis and Aims 
 
The hypothesis of this work was an independent monitor unit calculation algorithm using 
a superposition of open-field data could be used to calculate doses for SMLC and VMAT plans 
to within 2% for points in high-dose low gradient regions. Based on the results of the four aims, 
this hypothesis was not supported. 
 Aim 1 was to adapt the TomoTherapy independent dose calculation algorithm for 
calculation of dose from IMRT treatments delivered by a conventional MLC. This was done by 
developing a method to convert an arbitrary MLC pattern to the superposition of symmetric 
rectangular fields. IMRT treatments were then represented as the sum of multiple discrete field 
configurations called control points. The dose of each control point was calculated and then 
summed across the entire treatment.  
 Aim 2 was to obtain dosimetric data as required for input into the algorithm. Output 
factors of fields smaller than 3x3 cm
2
 were measured due to their rapid fall off at small field 
sizes. An exponential fits using the smaller field sizes down to 0x0 cm
2
 field size was used to 
extrapolate output factors for field sizes smaller than 1.5x1.5 cm
2
. 
 Aim 3 was to compare the algorithm and the current independent calculation method, 
MuCheck v8.2, to Pinnacle v9.0 calculations and point dose ion chamber measurements of the 
test cases presented in TG-119. These test cases are designed for commissioning a clinics IMRT 
calculation and delivery system. The geometries are representative of those encountered in the 
clinic. 
 Aim 4 was to investigate algorithm behavior by calculating a series of patient plans. 
Three sites, the prostate, neck, and chest wall were calculated for five patients, each having a 
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SMLC and VMAT plan for a total of 30 plans. Calculations were also done using MuCheck v8.2 
and both were compared against Pinnacle v9.2 calculations. 
Results of Aim 3 indicate that algorithm performance is optimal in high dose, low 
gradient regions such as the PTV and suffers when calculating dose to critical structures. This is 
acceptable as calculation points for secondary checks are placed in the PTV. In Aim 4, not all 
plans were able to meet the 2% criteria outlined in the thesis, therefore the hypothesis was not 
supported. However with a mean percent error ± 95% confidence interval of -0.2% ± 3.8% for 
the algorithm compared to MuCheck’s 0.7% ± 7.2% show that the algorithm is more accurate 
and noticeably more precise as a secondary check method than MuCheck. This is even without 
taking into account off-axis calculation points in VMAT plans for MuCheck which would 
significantly degrade performance. 
4.2 Clinical Implementation 
 
Algorithm performance has been demonstrated for a limited number of sites and should 
undergo a more rigorous commissioning process before clinical use. To implement this 
algorithm, a clinic would need to obtain open field beam data including TPRs, OARs, Sc, Sp, an 
average MLC leakage value, and the dose rate per monitor unit under normalization conditions. 
These data are already typically taken at time of machine commissioning and should be readily 
available.  
Not all clinics have output factors for fields as small as were used in the input data in this 
work. The algorithm’s reliance on output factors for field sizes smaller than 3x3-cm2 still needs 
to be investigated as mentioned in Section 4.3. 
The majority of patient specific data needed for plan calculation are available in DICOM 
treatment files and can be pulled from the TPS or a record and verify system. However, depth, 
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effective depth, and SSD along the source to point of calculation ray for each control point are 
not stored in the DICOM file. In this work, this information was extracted from Pinnacle using a 
custom script, but a more streamlined method needs to be developed. If the DICOM CT images 
were also imported into a program, these values could be independently calculated.  
Importing other treatment plan information such as control point dose or structure sets in 
addition to the CT images could have multiple advantages. Software with a user interface could 
be developed to allow the user to pick arbitrary calculation points and comparisons could be 
made on a control point basis. Cross plane profiles and possibly DVH comparisons could also be 
made, assuming algorithm performance outside the PTV sufficiently accurate. However, 
preliminary results seem to indicate that this is not the case. 
4.3 Future Work 
 
The observed systematic offsets as a function of calculation site deserve further 
investigation. Patient plans used in this project could all be delivered onto the same phantom 
geometry, recalculating with Pinnacle and the algorithm. If the site specific systematic offsets are 
still present in the algorithm calculations, than this indicates that the systematic errors are the 
results of field shapes common to each site, rather than differences in the patient geometry. This 
process would be further facilitated by being able to pull control point dose from Pinnacle, 
allowing for comparison of every field configuration instead of single beam or arc values. 
Small field output factors were measured for the calculations in this work and reliance of 
algorithm accuracy on these values should be investigated. Are output factors for fields smaller 
than 3x3-cm
2
 necessary, and how accurately do their values need to be known. Do actual 
measurements need to be taken or is there an extrapolation method based on data above a field 
size of 3x3-cm
2
 that gives acceptable results. Ideally the algorithm should be able to function 
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accurately without these values as the majority of institutions do not have small field output 
factors readily available. 
Sensitivity of the algorithm to changes in the average value of MLC leakage should also 
be investigated. This would have the largest impact on plans that use highly shaped fields, such 
as in the neck, as these plans have the most area of MLC leaves not under the photon collimating 
jaws.  
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Appendix A: Order of Superposition Illustrations  
 
The ± operators in Equation 2.4 take on different vales based on the position of the point 
of calculation relative to the leaf gap being calculated in the beam’s-eye-view. The point can be 
horizontally or vertically, inside or outside the leaf gap. This appendix contains illustrations of 
the four possible cases with their equations. Though unlikely, if the point of calculation is 
exactly on the boundary between two cases, the equations reduce to be equivalent since the 
dimension of some of the fields becomes zero. In the figures below the point of calculation is 
marked by the black dot and the single leaf gap is being calculated. The OAR weighting term 
from Equation 2.4 is denoted here as fOAR.  
 
 
 
Figure A.1: Point of calculation positioning case 1. 
        [(     )  (     )] 
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Figure A.2: Point of calculation positioning case 2. 
        [(     )  (     )] 
 
 
 
Figure A.3: Point of calculation positioning case 3. 
        [(     )  (     )] 
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Figure A.4: Point of calculation positioning case 4.  
        [(     )  (     )] 
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Appendix B: Open Field Data Used By Algorithm 
 
 This appendix contains all open field data as input into the algorithm for calculations in 
this work. 
 
Table B.1: Output Factors input into algorithm. 
 
6 MV Photons, Output Factors 
Field Size Sc Sp 
0.0 x 0.0 0.000 0.000 
0.1 x 0.1 0.242645 0.10783 
0.2 x 0.2 0.423511 0.202928 
0.3 x 0.3 0.558333 0.286742 
0.4 x 0.4 0.658833 0.360612 
0.5 x 0.5 0.733749 0.425717 
0.6 x 0.6 0.789593 0.483097 
0.7 x 0.7 0.83122 0.53367 
0.8 x 0.8 0.86225 0.578242 
0.9 x 0.9 0.885381 0.617525 
1.0 x 1.0 0.902623 0.652148 
1.1 x 1.1 0.915476 0.682662 
1.2 x 1.2 0.925056 0.709556 
1.3 x 1.3 0.932198 0.733259 
1.4 x 1.4 0.937522 0.75415 
1.5 x 1.5 0.941 0.768 
1.67 x 1.67 0.947 0.806 
2.0 x 2.0 0.950 0.834 
2.5 x 2.5 0.955 0.863 
3.0 x 3.0 0.957 0.880 
4.0 x 4.0 0.968 0.906 
5.0 x 5.0 0.975 0.922 
7.5 x 7.5 0.988 0.966 
10.0 x 10.0 1.000 1.000 
15.0 x 15.0 1.015 1.042 
20.0 x 20.0 1.024 1.073 
25.0 x 25.0 1.029 1.091 
30.0 x 30.0 1.034 1.106 
34.0 x 34.0 1.035 1.114 
40.0 x 40.0 1.033 1.125 
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Table B.2: Off-Axis ratios input into algorithm. 
 
6 MV Photons, Off-Axis Ratios 
OAD* 
[cm] 
Depth [cm] 
1.6 5 10 15 20 25 
0 1.000 1.000 1.000 1.000 1.000 1.000 
1 1.002 1.004 1.005 1.007 1.000 1.003 
2 1.008 1.009 1.008 1.007 1.004 1.005 
3 1.013 1.011 1.014 1.012 1.008 1.006 
4 1.019 1.018 1.016 1.012 1.006 1.004 
5 1.019 1.020 1.018 1.013 1.006 1.000 
6 1.021 1.017 1.015 1.012 1.002 0.995 
7 1.024 1.020 1.016 1.009 0.998 0.992 
8 1.033 1.026 1.019 1.008 0.998 0.990 
9 1.038 1.032 1.023 1.011 0.994 0.985 
10 1.044 1.035 1.025 1.008 0.992 0.977 
11 1.044 1.035 1.022 1.004 0.983 0.969 
12 1.046 1.035 1.019 0.997 0.977 0.955 
13 1.043 1.034 1.014 0.990 0.962 0.941 
14 1.047 1.033 1.009 0.979 0.952 0.926 
15 1.047 1.031 1.004 0.965 0.933 0.910 
16 1.044 1.023 0.990 0.944 0.906 0.888 
17 1.039 1.017 0.976 0.922 0.890 0.860 
18 1.034 1.002 0.953 0.902 0.859 0.827 
19 1.019 0.980 0.920 0.860 0.817 0.779 
20 0.573 0.538 0.518 0.495 0.516 0.437 
*Off Axis Distance is projected to 100 cm from souce. Data was 
taken from normalized profiles measured for the maximum 
square field size 
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Table B.3: Tissue Phantom Ratios for input into the algorithm. Field Sizes 3x3 cm
2
 to 14x14 
cm
2
. 
 
6 MV Photons, Tissue Phantom Ratios 
Field Size 3  x 3 4 x 4 5 x 5 6 x 6 7 x 7 8 x 8 9 x 9 10 x 10 11 x 11 12 x 12 13 x 13 14 x 14 
Depth [cm] 
        
    
0.0 0.547 0.561 0.573 0.585 0.597 0.607 0.618 0.628 0.637 0.646 0.654 0.661 
0.5 1.073 1.067 1.062 1.057 1.054 1.051 1.049 1.047 1.046 1.045 1.045 1.045 
1.0 1.308 1.293 1.279 1.266 1.255 1.245 1.235 1.227 1.219 1.213 1.207 1.202 
1.5 1.383 1.363 1.338 1.319 1.304 1.290 1.280 1.271 1.263 1.253 1.250 1.246 
2.0 1.379 1.359 1.337 1.320 1.304 1.290 1.279 1.270 1.261 1.250 1.246 1.240 
a 
        
    
2.5 1.362 1.343 1.323 1.307 1.292 1.279 1.269 1.260 1.251 1.241 1.237 1.231 
3.0 1.340 1.324 1.303 1.287 1.273 1.261 1.251 1.242 1.235 1.226 1.223 1.219 
3.5 1.317 1.303 1.285 1.270 1.258 1.246 1.237 1.229 1.222 1.213 1.211 1.206 
4.0 1.291 1.279 1.264 1.250 1.238 1.228 1.219 1.211 1.204 1.196 1.194 1.190 
4.5 1.267 1.257 1.242 1.230 1.220 1.211 1.204 1.198 1.192 1.184 1.182 1.178 
a 
        
    
5.0 1.238 1.230 1.219 1.209 1.201 1.192 1.186 1.179 1.173 1.165 1.164 1.160 
5.5 1.214 1.207 1.197 1.188 1.180 1.173 1.167 1.161 1.156 1.150 1.150 1.147 
6.0 1.185 1.181 1.173 1.166 1.160 1.154 1.149 1.145 1.141 1.136 1.133 1.130 
6.5 1.160 1.157 1.151 1.145 1.140 1.134 1.130 1.126 1.122 1.120 1.118 1.116 
7.0 1.139 1.135 1.129 1.123 1.119 1.115 1.112 1.109 1.106 1.104 1.102 1.100 
a 
        
    
7.5 1.115 1.112 1.106 1.102 1.098 1.095 1.093 1.091 1.089 1.087 1.085 1.083 
8.0 1.092 1.089 1.084 1.080 1.077 1.075 1.073 1.071 1.070 1.068 1.067 1.065 
8.5 1.069 1.068 1.064 1.060 1.057 1.055 1.054 1.053 1.052 1.052 1.051 1.051 
9.0 1.046 1.045 1.042 1.039 1.037 1.036 1.036 1.035 1.035 1.035 1.034 1.034 
9.5 1.023 1.023 1.022 1.022 1.021 1.020 1.020 1.019 1.018 1.018 1.018 1.018 
a 
        
    
10.0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 
10.5 0.980 0.979 0.978 0.978 0.978 0.979 0.981 0.981 0.982 0.983 0.984 0.985 
11.0 0.959 0.956 0.955 0.956 0.957 0.958 0.962 0.962 0.964 0.965 0.966 0.967 
11.5 0.938 0.938 0.936 0.936 0.938 0.939 0.943 0.944 0.946 0.949 0.950 0.952 
12.0 0.917 0.917 0.920 0.923 0.924 0.926 0.929 0.929 0.930 0.932 0.934 0.936 
a 
        
    
12.5 0.897 0.897 0.899 0.902 0.905 0.907 0.911 0.912 0.914 0.917 0.919 0.921 
13.0 0.880 0.878 0.879 0.883 0.885 0.888 0.892 0.893 0.896 0.898 0.901 0.903 
13.5 0.861 0.861 0.863 0.867 0.870 0.873 0.878 0.880 0.883 0.885 0.888 0.890 
14.0 0.839 0.842 0.844 0.846 0.850 0.853 0.858 0.860 0.864 0.867 0.870 0.872 
14.5 0.825 0.826 0.828 0.831 0.834 0.838 0.843 0.844 0.847 0.851 0.857 0.858 
a 
        
    
15.0 0.806 0.805 0.808 0.812 0.816 0.820 0.825 0.827 0.831 0.835 0.842 0.843 
15.5 0.790 0.791 0.794 0.797 0.800 0.804 0.810 0.812 0.816 0.820 0.826 0.828 
16.0 0.776 0.775 0.778 0.781 0.785 0.788 0.794 0.796 0.800 0.804 0.811 0.812 
16.5 0.756 0.756 0.758 0.762 0.766 0.770 0.776 0.779 0.784 0.789 0.795 0.797 
17.0 0.738 0.738 0.742 0.748 0.752 0.757 0.763 0.765 0.769 0.773 0.780 0.782 
a 
        
    
17.5 0.724 0.725 0.728 0.732 0.737 0.741 0.748 0.751 0.755 0.760 0.766 0.768 
18.0 0.711 0.710 0.711 0.714 0.719 0.724 0.731 0.735 0.742 0.748 0.755 0.757 
18.5 0.693 0.691 0.695 0.702 0.708 0.713 0.719 0.722 0.727 0.732 0.738 0.741 
19.0 0.681 0.682 0.684 0.687 0.692 0.697 0.704 0.707 0.713 0.719 0.725 0.727 
19.5 0.667 0.664 0.667 0.673 0.678 0.683 0.690 0.693 0.699 0.704 0.711 0.713 
a 
        
    
20.0 0.652 0.651 0.654 0.659 0.664 0.669 0.676 0.680 0.685 0.691 0.697 0.700 
21.0 0.624 0.619 0.622 0.629 0.635 0.641 0.649 0.653 0.659 0.665 0.672 0.676 
22.0 0.598 0.595 0.599 0.606 0.612 0.617 0.624 0.628 0.633 0.639 0.646 0.650 
23.0 0.574 0.572 0.575 0.579 0.585 0.590 0.597 0.603 0.608 0.614 0.623 0.627 
24.0 0.551 0.549 0.553 0.560 0.566 0.572 0.579 0.583 0.587 0.593 0.599 0.604 
a 
        
    
25.0 0.528 0.525 0.530 0.537 0.544 0.550 0.556 0.561 0.565 0.569 0.576 0.581 
26.0 0.511 0.507 0.511 0.517 0.523 0.529 0.535 0.540 0.544 0.549 0.556 0.561 
27.0 0.490 0.487 0.492 0.499 0.506 0.511 0.517 0.521 0.524 0.529 0.534 0.539 
28.0 0.469 0.464 0.466 0.472 0.478 0.484 0.490 0.496 0.500 0.506 0.513 0.519 
29.0 0.450 0.447 0.450 0.454 0.459 0.464 0.470 0.475 0.479 0.484 0.491 0.497 
30.0 0.431 0.428 0.430 0.434 0.440 0.444 0.451 0.455 0.459 0.465 0.472 0.477 
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Table B.4: Tissue Phantom Ratios for input into the algorithm. Field Sizes 15x15 cm
2
 to 28x28 
cm
2
. 
 
6 MV Photons, Tissue Phantom Ratios 
Field Size 15 x 15 16 x 16 17 x 17 18 x 18 19 x 19 20 x 20 21 x 21 22 x 22 24 x 24 26 x 26 28 x 28 
Depth [cm]             
0.0 0.668 0.675 0.681 0.686 0.691 0.696 0.700 0.703 0.708 0.711 0.712 
0.5 1.046 1.047 1.048 1.050 1.052 1.054 1.056 1.058 1.062 1.066 1.069 
1.0 1.198 1.194 1.191 1.188 1.186 1.184 1.183 1.181 1.180 1.179 1.178 
1.5 1.241 1.237 1.232 1.226 1.221 1.217 1.212 1.209 1.205 1.202 1.198 
2.0 1.235 1.230 1.226 1.221 1.217 1.213 1.208 1.205 1.203 1.199 1.196 
a              
2.5 1.226 1.221 1.216 1.211 1.206 1.202 1.197 1.194 1.191 1.189 1.187 
3.0 1.215 1.210 1.205 1.199 1.194 1.189 1.185 1.181 1.178 1.176 1.174 
3.5 1.202 1.198 1.193 1.188 1.183 1.179 1.176 1.173 1.172 1.170 1.166 
4.0 1.186 1.182 1.179 1.175 1.171 1.168 1.165 1.163 1.162 1.161 1.157 
4.5 1.174 1.170 1.166 1.161 1.158 1.154 1.151 1.148 1.147 1.145 1.143 
 a             
5.0 1.157 1.154 1.151 1.148 1.146 1.144 1.142 1.138 1.136 1.133 1.130 
5.5 1.145 1.142 1.139 1.135 1.132 1.129 1.125 1.122 1.120 1.118 1.117 
6.0 1.127 1.124 1.121 1.119 1.116 1.114 1.112 1.108 1.106 1.103 1.103 
6.5 1.114 1.113 1.110 1.107 1.104 1.101 1.099 1.096 1.094 1.093 1.092 
7.0 1.098 1.096 1.093 1.090 1.087 1.084 1.081 1.078 1.079 1.079 1.079 
a              
7.5 1.081 1.079 1.077 1.075 1.074 1.072 1.070 1.068 1.068 1.068 1.068 
8.0 1.064 1.063 1.061 1.059 1.058 1.056 1.055 1.054 1.054 1.055 1.055 
8.5 1.051 1.050 1.049 1.048 1.046 1.045 1.043 1.042 1.042 1.043 1.042 
9.0 1.033 1.033 1.032 1.032 1.031 1.030 1.029 1.029 1.029 1.029 1.028 
9.5 1.018 1.018 1.018 1.017 1.016 1.015 1.014 1.013 1.014 1.014 1.015 
 a             
10.0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 
10.5 0.986 0.986 0.986 0.986 0.986 0.986 0.986 0.986 0.986 0.986 0.987 
11.0 0.968 0.968 0.969 0.969 0.969 0.969 0.969 0.970 0.971 0.972 0.973 
11.5 0.953 0.954 0.955 0.955 0.956 0.956 0.956 0.956 0.956 0.957 0.959 
12.0 0.938 0.939 0.941 0.941 0.941 0.941 0.940 0.940 0.941 0.943 0.945 
 a             
12.5 0.923 0.924 0.926 0.926 0.926 0.926 0.926 0.926 0.927 0.929 0.931 
13.0 0.905 0.907 0.909 0.910 0.911 0.912 0.912 0.913 0.915 0.917 0.919 
13.5 0.891 0.893 0.895 0.896 0.898 0.900 0.901 0.903 0.905 0.907 0.908 
14.0 0.875 0.877 0.878 0.880 0.882 0.883 0.885 0.886 0.888 0.889 0.891 
14.5 0.861 0.864 0.867 0.869 0.871 0.872 0.873 0.874 0.875 0.877 0.878 
 a             
15.0 0.847 0.850 0.853 0.855 0.856 0.857 0.858 0.859 0.860 0.863 0.865 
15.5 0.832 0.835 0.838 0.840 0.842 0.843 0.844 0.845 0.847 0.849 0.852 
16.0 0.816 0.819 0.823 0.825 0.827 0.829 0.831 0.832 0.835 0.838 0.841 
16.5 0.800 0.804 0.807 0.809 0.812 0.814 0.816 0.818 0.821 0.825 0.828 
17.0 0.786 0.789 0.793 0.796 0.798 0.801 0.803 0.805 0.808 0.812 0.815 
 a             
17.5 0.772 0.776 0.779 0.782 0.784 0.787 0.789 0.792 0.797 0.800 0.804 
18.0 0.761 0.765 0.768 0.771 0.773 0.775 0.777 0.779 0.783 0.785 0.787 
18.5 0.745 0.749 0.753 0.756 0.759 0.762 0.765 0.767 0.772 0.774 0.777 
19.0 0.731 0.735 0.738 0.741 0.745 0.748 0.751 0.754 0.760 0.762 0.765 
19.5 0.717 0.721 0.725 0.728 0.731 0.735 0.738 0.741 0.747 0.750 0.753 
 a             
20.0 0.704 0.708 0.712 0.716 0.719 0.723 0.726 0.729 0.735 0.738 0.741 
21.0 0.680 0.684 0.688 0.692 0.695 0.699 0.702 0.705 0.710 0.713 0.717 
22.0 0.655 0.660 0.665 0.669 0.673 0.676 0.679 0.681 0.686 0.689 0.693 
23.0 0.633 0.638 0.643 0.648 0.652 0.654 0.656 0.658 0.662 0.665 0.669 
24.0 0.607 0.611 0.615 0.619 0.623 0.626 0.630 0.633 0.640 0.644 0.649 
 a             
25.0 0.584 0.589 0.593 0.597 0.601 0.605 0.609 0.612 0.619 0.624 0.629 
26.0 0.564 0.568 0.573 0.577 0.581 0.586 0.590 0.593 0.601 0.605 0.609 
27.0 0.542 0.547 0.551 0.555 0.559 0.563 0.567 0.570 0.577 0.582 0.587 
28.0 0.523 0.528 0.533 0.538 0.543 0.547 0.551 0.554 0.561 0.565 0.568 
29.0 0.502 0.507 0.512 0.517 0.522 0.526 0.529 0.532 0.538 0.542 0.547 
30.0 0.482 0.487 0.492 0.497 0.502 0.506 0.510 0.513 0.521 0.526 0.531 
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Table B.5: Tissue Phantom Ratios for input into the algorithm. Field Sizes 30x30 cm
2
 to 40x40 
cm
2
. 
 
 6 MV Photons, Tissue Phantom Ratios 
Field Size 30 x 30 32 x 32 34 x 34 36 x 36 38 x 38 40 x 40 
Depth [cm]        
0.0 0.711 0.707 0.702 0.695 0.685 0.674 
0.5 1.071 1.072 1.071 1.068 1.063 1.054 
1.0 1.177 1.175 1.172 1.167 1.160 1.150 
1.5 1.195 1.192 1.189 1.185 1.180 1.175 
2.0 1.193 1.190 1.186 1.181 1.176 1.170 
 a        
2.5 1.185 1.182 1.177 1.173 1.168 1.163 
3.0 1.173 1.170 1.166 1.163 1.160 1.157 
3.5 1.163 1.159 1.157 1.155 1.151 1.147 
4.0 1.153 1.150 1.147 1.144 1.141 1.137 
4.5 1.141 1.138 1.136 1.134 1.131 1.128 
 a        
5.0 1.128 1.127 1.126 1.125 1.122 1.117 
5.5 1.116 1.116 1.114 1.112 1.109 1.106 
6.0 1.103 1.104 1.101 1.098 1.096 1.093 
6.5 1.091 1.089 1.088 1.087 1.085 1.082 
7.0 1.079 1.079 1.077 1.075 1.073 1.071 
 a        
7.5 1.068 1.067 1.066 1.064 1.062 1.060 
8.0 1.055 1.054 1.052 1.051 1.049 1.048 
8.5 1.041 1.039 1.039 1.040 1.040 1.039 
9.0 1.028 1.027 1.027 1.027 1.027 1.026 
9.5 1.015 1.014 1.014 1.013 1.013 1.012 
 a        
10.0 1.000 1.000 1.000 1.000 1.000 1.000 
10.5 0.988 0.989 0.989 0.989 0.988 0.987 
11.0 0.974 0.975 0.976 0.976 0.976 0.975 
11.5 0.961 0.963 0.964 0.964 0.963 0.962 
12.0 0.945 0.945 0.946 0.948 0.950 0.950 
 a        
12.5 0.934 0.936 0.938 0.938 0.937 0.937 
13.0 0.922 0.924 0.925 0.925 0.924 0.924 
13.5 0.909 0.910 0.912 0.913 0.915 0.915 
14.0 0.893 0.895 0.897 0.900 0.903 0.904 
14.5 0.881 0.884 0.888 0.890 0.891 0.892 
 a        
15.0 0.869 0.872 0.876 0.877 0.877 0.877 
15.5 0.856 0.859 0.862 0.864 0.866 0.868 
16.0 0.843 0.846 0.848 0.850 0.852 0.854 
16.5 0.831 0.834 0.836 0.838 0.840 0.842 
17.0 0.818 0.821 0.824 0.825 0.826 0.827 
 a        
17.5 0.807 0.810 0.813 0.814 0.816 0.817 
18.0 0.790 0.794 0.797 0.801 0.803 0.806 
18.5 0.780 0.785 0.789 0.792 0.793 0.794 
19.0 0.767 0.771 0.775 0.779 0.782 0.785 
19.5 0.756 0.759 0.763 0.766 0.769 0.771 
 a        
20.0 0.744 0.748 0.753 0.756 0.759 0.762 
21.0 0.721 0.725 0.729 0.732 0.734 0.736 
22.0 0.696 0.700 0.704 0.707 0.710 0.713 
23.0 0.673 0.678 0.683 0.688 0.691 0.693 
24.0 0.653 0.658 0.662 0.666 0.670 0.673 
 a        
25.0 0.633 0.638 0.641 0.645 0.648 0.651 
26.0 0.613 0.616 0.620 0.624 0.628 0.632 
27.0 0.591 0.596 0.600 0.604 0.608 0.611 
28.0 0.571 0.575 0.580 0.585 0.590 0.593 
29.0 0.553 0.558 0.563 0.567 0.571 0.574 
30.0 0.536 0.542 0.546 0.550 0.553 0.556 
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Appendix C: Results of TG-119 Phantom Calculations 
 
 This appendix contains full results of all TG-119 plans calculated according to Aim 3. 
Table C.1 to Table C.4 show the results of both calculation methods as compared against ion 
chamber measurements. 
 Table C.5 to Table C.8 show the results of both calculation methods as compared against 
calculations of the Pinnacle TPS. Calculations below 2% error are highlighted green, 3% to 5% 
are yellow, and above 5% are red. 
Table C.1: Multitarget plans compared to ion chamber measurements. 
 
Multitarget Plans 
Modality Point 
Measured 
Dose (cGy) 
[Mean ± SD] 
MuCheck 
Dose (cGy) 
% Error 
Algorithm 
Dose (cGy) 
% Error 
SMLC 
50 Gy 213.9 ± 0.3 212.1 -0.8 211.7 -1.4 
25 Gy 118.5 ± 0.9 111.1 -6.2 119.9 -1.5 
12.5 Gy 59.8 ± 0.5 51.2 -14.3 60.7 -5.5 
VMAT 
50 Gy 219.0 ± 0.2 211.6 -3.4 218.5 0.0 
25 Gy 108.0 ± 0.2 112.0 3.7 106.2 -1.5 
12.5 Gy 53.7 ± 0.2 50.2 -6.4 49.7 -11.5 
 
Table C.2: Mock Prostate plans compared to ion chamber measurements. 
 
Mock Prostate Plans 
Modality Point 
Measured 
Dose (cGy) 
[Mean ± SD] 
MuCheck 
Dose (cGy) 
% Error 
Algorithm 
Dose (cGy) 
% Error 
SMLC 
PTV 182.6 ± 0.2 181.4 -0.7 180.3 -2.0 
Rectum 134.4 ± 0.5 142.1 5.8 126.2 -5.0 
Bladder 138.8 ± 0.8 - - 140.0 -1.0 
VMAT 
PTV 184.3 ± 0.3 181.6 -1.5 183.0 -1.2 
Rectum 144 ± 0.3 181.9 26.3 141.4 -1.3 
Bladder 129.4 ± 0.8 183.2 41.6 131.2 -4.0 
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Table C.3: Mock Neck plans compared to ion chamber measurements. 
 
Mock Neck Plans 
Modality Point 
Measured 
Dose (cGy) 
[Mean ± SD] 
MuCheck 
Dose (cGy) 
% Error 
Algorithm 
Dose (cGy) 
% Error 
SMLC 
PTV 207.1 ±  0.0 205.5 -0.8 209.9 -1.5 
Spinal Cord 124.1 ± 1.4 146.6 18.1 118.0 -4.3 
VMAT 
PTV 198.0 ± 0.3 204.4 3.2 198.5 -3.7 
Spinal Cord 127.4 ± 0.9 218.8 71.7 123.3 -7.9 
 
 
Table C.4: C-shape plans compared to ion chamber measurements. 
 
C-shape Plans 
Modality Point 
Measured 
Dose (cGy) 
[Mean ± SD] 
MuCheck 
Dose (cGy) 
% Error 
Algorithm 
Dose (cGy) 
% Error 
SMLC 
PTV 212.0 ± 0.3 - - 205.8 -1.0 
Core 53.2 ± 0.3 46.6 -12.4 50.3 -9.5 
VMAT 
PTV 202.0 ± 0.7 43.1 -78.7 204.9 -1.4 
Core 44.0 ± 0.3 16.6 -62.2 41.8 -12.6 
 
Table C.5: Multitarget plans compared to Pinnacle calculations.  
Multitarget Plans 
Modality Point 
Pinnacle 
Dose (cGy) 
MuCheck 
Dose (cGy) 
% Error 
Algorithm 
Dose (cGy) 
% Error 
SMLC 
50 Gy 214.7 212.1 -1.2 211.7 -1.1 
25 Gy 121.7 111.1 -8.6 119.9 1.2 
12.5 Gy 64.3 51.2 -20.3 60.7 1.6 
VMAT 
50 Gy 218.6 211.6 -3.2 218.5 -0.2 
25 Gy 107.8 112.0 3.9 106.2 -1.7 
12.5 Gy 56.2 50.2 -10.6 49.7 -7.4 
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Table C.6: Mock Prostate plans compared to Pinnacle calculations.  
 
Mock Prostate Plans 
Modality Point 
Pinnacle 
Dose (cGy) 
MuCheck 
Dose (cGy) 
% Error 
Algorithm 
Dose (cGy) 
% Error 
SMLC 
PTV 184.0 181.4 -1.4 180.3 -1.3 
Rectum 132.9 142.1 7.0 126.2 -6.1 
Bladder 141.3 - - 140.0 0.8 
VMAT 
PTV 185.3 181.6 -2.0 183.0 -0.7 
Rectum 143.3 181.9 27.0 141.4 -1.8 
Bladder 136.7 183.2 34.1 131.2 1.4 
 
 
Table C.7: Mock Neck plans compared to Pinnacle calculations. 
 
Mock Neck Plans 
Modality Point 
Pinnacle 
Dose (cGy) 
MuCheck 
Dose (cGy) 
% Error 
Algorithm 
Dose (cGy) 
% Error 
SMLC 
PTV 213.0 205.5 -3.5 209.9 1.4 
Spinal Cord 123.3 146.6 18.9 118.0 -4.9 
VMAT 
PTV 206.2 204.4 -0.9 198.5 0.3 
Spinal Cord 133.9 218.8 63.4 123.3 -3.2 
 
 
Table C.8: C-shape plans compared to Pinnacle calculations. 
 
C-shape Plans 
Modality Point 
Pinnacle 
Dose (cGy) 
MuCheck 
Dose (cGy) 
% Error 
Algorithm 
Dose (cGy) 
% Error 
SMLC 
PTV 207.9 - - 205.8 -2.9 
Core 55.6 46.6 -16.2 50.3 -5.4 
VMAT 
PTV 207.7 43.1 -79.3 204.9 1.4 
Core 47.8 16.6 -65.2 41.8 -5.0 
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Appendix D: Results of Patient Plan Calculation 
 
This appendix full results of all patient plans as calculated according to aim 4. Table D.1 
to Table D.3 show the plan dose values for both calculation methods as compared to Pinnacle. 
Calculations below 2% error are highlighted in green, 3% to 5% are yellow, and above 5% are 
red. 
Table D.1: Results for patient prostate plans. 
 
Prostate Plans 
Modality 
Pinnacle Dose 
(cGy) 
MuCheck Dose 
(cGy) 
% Error 
Algorithm Dose 
(cGy) 
% Error 
SMLC 
200.5 196.4 -2.0 196.1 -2.2 
199.9 196.3 -1.8 195.2 -2.4 
200.6 194.9 -2.9 196.0 -2.3 
200.8 198.3 -1.2 198.3 -1.2 
200.7 193.3 -3.7 196.8 -1.9 
VMAT 
200.0 206.2 3.1 196.1 -1.9 
200.2 199.7 -0.2 195.5 -2.3 
200.1 205.1 2.5 194.6 -2.8 
199.9 204.2 2.2 196.2 -1.8 
200.1 187.6 -6.2 194.9 -2.6 
 
 
 65 
 
Table D.2: Results for patient neck plans. 
 
Neck Plans 
Modality 
Pinnacle 
Dose (cGy) 
MuCheck 
Dose (cGy) 
% Error 
Algorithm Dose 
(cGy) 
% Error 
SMLC 
203.2 205.2 1.0 204.4 0.6 
200.2 213.3 6.5 200.5 0.2 
199.5 218.5 9.5 200.8 0.7 
200.5 198.7 -0.9 198.9 -0.8 
199.3 199.7 0.2 198.5 -0.4 
VMAT 
200.2 192.2 -4.0 194.5 -2.8 
200.3 181.6 -9.3 200.2 0.0 
200.0 181.3 -9.3 203.0 1.5 
204.0 228.2 11.8 201.3 -1.3 
254.3 288.0 13.2 252.4 -0.8 
 
 
Table D.3: Results for patient chest wall plans. 
 
Chest Wall Plans 
Modality 
Pinnacle 
Dose (cGy) 
MuCheck 
Dose (cGy) 
% Error 
Algorithm 
Dose (cGy) 
% Error 
SMLC 
200.0 202.0 1.0 205.4 2.7 
199.9 204.3 2.2 209.7 4.9 
199.9 211.3 5.7 203.8 1.9 
200.1 197.9 -1.1 203.5 1.7 
200.0 200.3 0.2 201.9 1.0 
VMAT 
200.2 149.8 -25.2 202.9 1.4 
202.1 112.6 -44.3 205.8 1.8 
199.7 104.2 -47.8 203.1 1.7 
235.9 151.9 -35.6 237.3 0.6 
200.1 218.3 9.1 201.4 0.6 
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